In this study, in order to increase the concentration of simvastatin at the active site, a liposomal delivery system containing simvastatin was used, which was found to inhibit tumor growth, possibly due to the reduction in oxidative stress caused by macrophages, via the inhibition of intra-tumoral HIF-1α [119]. This evidence concerns the gene HIF1A and neoplasm.